Sanofi India Limited (SANOFI) | Stock Overview & Key Data
Sanofi India Limited Performance Comparison
Stock Range
Today's Range
Low: ₹5,054.00
High: ₹5,121.50
on August 13, 2025
52 Week Range
Low: ₹4,902.00
High: ₹7,600.00
on February 28, 2025
on September 6, 2024
All-Time High: ₹10,524.95 on June 10, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR119.9B
EPS
157.54
P/E Ratio (TTM)
33.00
Forward P/E
25.52
P/B Ratio
15.31
PEG Ratio
25.52
Div. Yield
1.93%
ROE
49.43%
Beta
0.083
Debt to Equity
2.67
Financial Highlights
Profitability
Gross Margin
48.63%
Operating Margin
21.12%
Profit Margin
18.29%
Returns and Earnings
Return on Assets (TTM)
22.47%
Return on Equity (TTM)
49.43%
EBITDA
INR5.2B
Net Income (TTM)
INR3.6B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR860.20
Quarterly Revenue Growth (YoY)
-12.30%
Quarterly Earnings Growth (YoY)
-32.70%
Dividend Information
Last 12-Month Dividend
₹117.00
Current Dividend Yield
1.93%
3-Year Average Dividend Yield
2.07%
3-Year Average Annual Dividend
₹220.00
3-Year Total Dividends
₹660.00
Ex-Dividend Date
April 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sanofi India Limited SANOFI | 119.89B Mid-cap | -5.91% | -14.06% | -12.99% | -5.04% | -16.33% | -23.97% | -19.35% | -41.99% |
| GlaxoSmithKline GLAXO | 455.21B Large-cap | -8.49% | -18.80% | -4.88% | 27.49% | 15.98% | -7.10% | 82.41% | 80.88% |
| Pfizer PFIZER | 228.51B Large-cap | 0.23% | -5.71% | 20.06% | 23.82% | -3.87% | -13.51% | 19.04% | 9.92% |
| Sanofi Consumer SANOFICONR | 119.55B Mid-cap | -3.02% | -0.30% | 4.63% | 8.62% | 4.55% | 5.78% | 5.78% | 5.78% |
| Marksans Pharma MARKSANS | 95.61B Mid-cap | -17.27% | -28.34% | -16.15% | -26.54% | -38.70% | 0.51% | 312.33% | 297.50% |
| Senores SENORES | 30.21B Small-cap | -0.48% | 9.89% | 31.82% | 26.97% | 17.81% | 15.47% | 15.47% | 15.47% |
Ownership & Short Interest
Insider Ownership
60.61%
Institutional Ownership
26.29%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
13K
Average 90-Day Volume
11K
Sanofi India Limited Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sanofi India Limited would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SANOFI's 52-week high and low?
- In the last 52 weeks, Sanofi India Limited reached a high of ₹7,600.00 (on September 6, 2024) and a low of ₹4,902.00 (on February 28, 2025).
- What is the market cap and P/E ratio for SANOFI?
- Curious about Sanofi India Limited's size and valuation? Its market capitalization stands at 119.89B. When it comes to valuation, the P/E ratio (trailing twelve months) is 33.00, and the forward P/E (looking ahead) is 25.52.
- Does SANOFI pay dividends? If so, what's the yield?
- Yes, Sanofi India Limited is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.93%, and the company has paid an average of ₹220.00 per share annually over the past 3 years.
- Who are Sanofi India Limited's main competitors or similar companies to consider before investing?
When looking at Sanofi India Limited, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO455.21B Healthcare Drug Manufacturers - General -7.10% 82.41% Pfizer
PFIZER228.51B Healthcare Drug Manufacturers - General -13.51% 19.04% Sanofi Consumer
SANOFICONR119.55B Healthcare Drug Manufacturers - General 5.78% 5.78% Marksans Pharma
MARKSANS95.61B Healthcare Drug Manufacturers - General 0.51% 312.33% Senores
SENORES30.21B Healthcare Drug Manufacturers - General 15.47% 15.47% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sanofi India Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Sanofi India Limited's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 49.43%, the Debt to Equity ratio from the most recent quarter is 2.67, and its Gross Profit Margin stands at 48.63%.
- What is the recent revenue and earnings growth for SANOFI?
- Looking at Sanofi India Limited's growth, its revenue over the trailing twelve months (TTM) was INR20B. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.30%, and quarterly earnings saw a YoY growth of -32.70%.
- How much of SANOFI stock is held by insiders and institutions?
- Wondering who owns Sanofi India Limited stock? Company insiders (like executives and directors) hold about 60.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 26.29%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.